Get the Stockscreener App
2.1296
0.94%
-0.0096
Phio Pharmaceuticals Corp stock is traded at $2.1296, with a volume of 17,516.
It is down -0.94% in the last 24 hours and down -5.83% over the past month.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
See More
Previous Close:
$2.12
Open:
$2.13
24h Volume:
17,516
Relative Volume:
0.02
Market Cap:
$12.08M
Revenue:
-
Net Income/Loss:
$-11.66M
P/E Ratio:
-0.2611
EPS:
-8.156
Net Cash Flow:
$-11.09M
1W Performance:
-2.78%
1M Performance:
-5.83%
6M Performance:
+2.94%
1Y Performance:
-27.84%
1-Day Range:
$2.08
$2.13
1-Week Range:
$2.06
$2.16
52-Week Range:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Name
Phio Pharmaceuticals Corp
Sector
Industry
Phone
(508) 767-3861
Address
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Compare PHIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
2.11 | 12.14M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.89 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.96 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
582.64 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
820.00 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.51 | 34.14B | 4.56B | -176.77M | 225.30M | -1.7177 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Resumed | H.C. Wainwright | Buy |
| Aug-05-20 | Initiated | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Stock (PHIO) Latest News
How currency fluctuations impact Phio Pharmaceuticals Corp. stock2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Can Phio Pharmaceuticals Corp. hit a new high this month2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
Analyzing Phio Pharmaceuticals Corp. with multi timeframe chartsWall Street Watch & Community Verified Swing Trade Signals - newser.com
Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025Market Activity Report & Free Technical Confirmation Trade Alerts - newser.com
Using economic indicators to assess Phio Pharmaceuticals Corp. potentialMarket Volume Summary & Technical Pattern Alert System - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock attractive for growth fundsSwing Trade & Fast Momentum Stock Entry Tips - newser.com
What to do if you’re stuck in Phio Pharmaceuticals Corp.Market Rally & Smart Investment Allocation Tips - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. dataQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Will Phio Pharmaceuticals Corp. stock rally after Fed decisionsVolume Spike & Technical Confirmation Trade Alerts - newser.com
Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
How Phio Pharmaceuticals Corp. stock benefits from tech adoptionBond Market & Capital Efficiency Focused Ideas - newser.com
Phio Pharmaceuticals Corp Stock (PHIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phio Pharmaceuticals Corp Stock (PHIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ferrara Robert L | Director |
Jun 10 '25 |
Buy |
2.42 |
2,500 |
6,050 |
15,666 |
| Bitterman Robert J | Chairman, Pres & CEO |
Jun 09 '25 |
Buy |
2.75 |
1,500 |
4,125 |
25,149 |
| Bitterman Robert J | Chairman, Pres & CEO |
May 21 '25 |
Buy |
1.77 |
3,000 |
5,310 |
22,449 |
| Bitterman Robert J | Chairman, Pres & CEO |
May 22 '25 |
Buy |
1.78 |
1,200 |
2,136 |
23,649 |
| Ferrara Robert L | Director |
May 20 '25 |
Buy |
1.82 |
2,500 |
4,550 |
13,166 |
0.42%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):